Skip to main
ALC

ALC Stock Forecast & Price Target

ALC Analyst Ratings

Based on 11 analyst ratings
Buy
Strong Buy 18%
Buy 36%
Hold 36%
Sell 9%
Strong Sell 0%

Bulls say

Alcon is a leading global visioncare and surgical company that has recently been spun off from Novartis, and our positive outlook on the stock is based on their strong position in the market, diverse product portfolio, and potential for future growth. Additionally, recent launches such as the Unity platform and PanOptix Pro have helped boost market share in the surgical segment and show potential for continued success. With a solid capital allocation strategy and potential for margin improvement, we believe Alcon has the potential to outperform in the long term.

Bears say

Alcon is experiencing weak demand in its Vision Care segment, driven by slower market growth and increased competition. This, combined with higher costs and limited margin expansion, suggests that the company's stock will remain range-bound. Despite strong new product adoption, including Precision7 and Systane Pro, the overall outlook for Alcon's financials is not positive, with sales and earnings growth expected to be below the company's forecast.

ALC has been analyzed by 11 analysts, with a consensus rating of Buy. 18% of analysts recommend a Strong Buy, 36% recommend Buy, 36% suggest Holding, 9% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Alcon Inc. - Registered Shares and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Alcon Inc. - Registered Shares (ALC) Forecast

Analysts have given ALC a Buy based on their latest research and market trends.

According to 11 analysts, ALC has a Buy consensus rating as of Jun 17, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $83.78, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $83.78, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Alcon Inc. - Registered Shares (ALC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.